259 related articles for article (PubMed ID: 15213228)
21. Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family.
Monti E; Bassi MT; Bresciani R; Civini S; Croci GL; Papini N; Riboni M; Zanchetti G; Ballabio A; Preti A; Tettamanti G; Venerando B; Borsani G
Genomics; 2004 Mar; 83(3):445-53. PubMed ID: 14962670
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex.
Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV
Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332
[TBL] [Abstract][Full Text] [Related]
23. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane.
Monti E; Bassi MT; Papini N; Riboni M; Manzoni M; Venerando B; Croci G; Preti A; Ballabio A; Tettamanti G; Borsani G
Biochem J; 2000 Jul; 349(Pt 1):343-51. PubMed ID: 10861246
[TBL] [Abstract][Full Text] [Related]
24. Sialidase NEU3 and its pathological significance.
Miyagi T; Yamamoto K
Glycoconj J; 2022 Oct; 39(5):677-683. PubMed ID: 35675020
[TBL] [Abstract][Full Text] [Related]
25. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.
Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA
Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530
[TBL] [Abstract][Full Text] [Related]
26. Identification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytes.
D'Avila F; Tringali C; Papini N; Anastasia L; Croci G; Massaccesi L; Monti E; Tettamanti G; Venerando B
J Cell Biochem; 2013 Jan; 114(1):204-11. PubMed ID: 22903576
[TBL] [Abstract][Full Text] [Related]
27. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.
Cross AS; Hyun SW; Miranda-Ribera A; Feng C; Liu A; Nguyen C; Zhang L; Luzina IG; Atamas SP; Twaddell WS; Guang W; Lillehoj EP; Puché AC; Huang W; Wang LX; Passaniti A; Goldblum SE
J Biol Chem; 2012 May; 287(19):15966-80. PubMed ID: 22403397
[TBL] [Abstract][Full Text] [Related]
28. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.
Pshezhetsky AV; Richard C; Michaud L; Igdoura S; Wang S; Elsliger MA; Qu J; Leclerc D; Gravel R; Dallaire L; Potier M
Nat Genet; 1997 Mar; 15(3):316-20. PubMed ID: 9054950
[TBL] [Abstract][Full Text] [Related]
29. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
[TBL] [Abstract][Full Text] [Related]
30. Identification and expression of Neu4, a novel murine sialidase.
Comelli EM; Amado M; Lustig SR; Paulson JC
Gene; 2003 Dec; 321():155-61. PubMed ID: 14637003
[TBL] [Abstract][Full Text] [Related]
31. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A
Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for substrate specificity of mammalian neuraminidases.
Smutova V; Albohy A; Pan X; Korchagina E; Miyagi T; Bovin N; Cairo CW; Pshezhetsky AV
PLoS One; 2014; 9(9):e106320. PubMed ID: 25222608
[TBL] [Abstract][Full Text] [Related]
33. Evidence for mitochondrial localization of a novel human sialidase (NEU4).
Yamaguchi K; Hata K; Koseki K; Shiozaki K; Akita H; Wada T; Moriya S; Miyagi T
Biochem J; 2005 Aug; 390(Pt 1):85-93. PubMed ID: 15847605
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.
Vinogradova MV; Michaud L; Mezentsev AV; Lukong KE; El-Alfy M; Morales CR; Potier M; Pshezhetsky AV
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):641-50. PubMed ID: 9480870
[TBL] [Abstract][Full Text] [Related]
35. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
[TBL] [Abstract][Full Text] [Related]
36. Acidic sialidase activity is aberrant in obese and diabetic mice.
Natori Y; Ohkura N; Nasui M; Atsumi G; Kihara-Negishi F
Biol Pharm Bull; 2013; 36(6):1027-31. PubMed ID: 23727924
[TBL] [Abstract][Full Text] [Related]
37. Mammalian sialidases: physiological and pathological roles in cellular functions.
Miyagi T; Yamaguchi K
Glycobiology; 2012 Jul; 22(7):880-96. PubMed ID: 22377912
[TBL] [Abstract][Full Text] [Related]
38. Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient.
Uhl J; Penzel R; Sergi C; Kopitz J; Otto HF; Cantz M
FEBS Lett; 2002 Jun; 521(1-3):19-23. PubMed ID: 12067718
[TBL] [Abstract][Full Text] [Related]
39. A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.
Alghamdi F; Guo M; Abdulkhalek S; Crawford N; Amith SR; Szewczuk MR
Cell Signal; 2014 Jun; 26(6):1355-68. PubMed ID: 24583283
[TBL] [Abstract][Full Text] [Related]
40. A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse.
Rottier RJ; Bonten E; d'Azzo A
Hum Mol Genet; 1998 Feb; 7(2):313-21. PubMed ID: 9425240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
